Dr. Akash Mavle
Angel investor in New York
Invests in AIDr. Akash Mavle's investor profile lists AI alongside Healthcare & Biotech and Cybersecurity, at seed and early-stage venture. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.
Email InvestorCredits to line up before a seed round
Dr. Akash Mavle backs companies at seed and early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech, Cybersecurity
- Rounds
- Seed, Early-stage venture
- Profile
- Angel investor
- Deals on record
- None yet
- Based in
- New York, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Esther DysonAngel investor in New York City
- Alex IskoldFounder and Partner at 2048 Ventures
- Bill CoughranFounder's Coach and Partner at Sequoia Capital
- Adam BergerVenture investor in Santa Barbara
- Adam ValkinManaging Director at Vine Ventures
- Nikitas KoutoupesManaging Director at Insight Partners
- Mike KrupkaSenior Advisor at Bain Capital Ventures
- Semyon DukachAngel investor in Boston
Questions founders ask
- Does Dr. Akash Mavle invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Dr. Akash Mavle's investor profile, together with Healthcare & Biotech and Cybersecurity. The stages on record are seed and early-stage venture.
- What credits can a startup claim before pitching Dr. Akash Mavle?
- For a company raising a seed round, AI Perks lists credits such as Algolia (up to $10,000), MongoDB (up to $25,000), Confluent (up to $20,000) and WordPress VIP (up to $20,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal